Given the recognized 99% identity between human and mouse HSP90α, we followed our previously reported schedule for assessing a mouse monoclonal antibody to evaluate the cancer-preventive activity of HH01 in the mouse model of EndoMT-involved PDAC. This evidence concerns the gene HSP90AA1 and cancer.